California 2015-2016, 2nd Special Session Status: Introduced 2 R cosponsors

AB 12 — Cadaveric fetal tissue.

Last action — Died at Desk.

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2015-2016, 2nd Special Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Existing law prohibits a person from knowingly, for valuable consideration, purchasing or selling embryonic or cadaveric fetal tissue for research purposes, pursuant to specified provisions of law. Existing law, for the purpose of this provisions, excludes from the definition of "valuable consideration" reasonable payment for the removal, processing, disposal, preservation, quality control, storage, transplantation, or implantation of a part. This bill would, for the purpose of that provision, instead include in the definition of "valuable consideration" all forms of payment, including, but not limited to, payment for the removal, processing, disposal, preservation, quality control, storage, transplantation, or implantation of a part. The bill would also prohibit public funds from being used to support any facility that furnishes cadaveric fetal tissue for research. The California Stem Cell Research and Cures Act, an initiative measure approved by the voters at the November 2, 2004, statewide general election as Proposition 71, provides that the Legislature may amend the nonbond statutory provisions of that act to enhance the ability of the California Institute for Regenerative Medicine to further the purposes of the grant and loan programs created by that act, with a 70% vote of each house and compliance with specified procedural requirements. Because this bill would amend certain provisions of the act, it would require for passage a 70% vote.

Bill Text

What changed in the latest version

1 added · 1 removed

1 line(s) added, 1 removed.

→
Previous
Latest
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill TextBill Information PDF2 Bill PDF |Add To My Favorites | Version:
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill Text PDF2 Bill PDF |Add To My Favorites | Version:
⬇ Download PDF
View plain text versions (2)

Action History

  1. Died at Desk.

  2. From printer.

  3. Read first time. To print.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 4 co-sponsors · 117 not signed on

Sponsors (1)

Co-sponsors (4)

Not signed on (117)

117 members have not signed on to this bill.

Show all 117 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare technology
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does AB 12 do?
Existing law prohibits a person from knowingly, for valuable consideration, purchasing or selling embryonic or cadaveric fetal tissue for research purposes, pursuant to specified provisions of law. Existing law, for the purpose of this provisions, excludes from the definition of "valuable consideration" reasonable payment for the removal, processing, disposal, preservation, quality control, storage, transplantation, or implantation of a part. This bill would, for the purpose of that provision, instead include in the definition of "valuable consideration" all forms of payment, including, but not limited to, payment for the removal, processing, disposal, preservation, quality control, storage, transplantation, or implantation of a part. The bill would also prohibit public funds from being used to support any facility that furnishes cadaveric fetal tissue for research. The California Stem Cell Research and Cures Act, an initiative measure approved by the voters at the November 2, 2004, statewide general election as Proposition 71, provides that the Legislature may amend the nonbond statutory provisions of that act to enhance the ability of the California Institute for Regenerative Medicine to further the purposes of the grant and loan programs created by that act, with a 70% vote of each house and compliance with specified procedural requirements. Because this bill would amend certain provisions of the act, it would require for passage a 70% vote.
Who sponsors AB 12?
AB 12 is sponsored by Wagner, Mathis, Grove, Shannon (Republican), Jones, and Patterson, Joe (Republican).
What is the current status of AB 12?
This bill died with 2015-2016, 2nd Special Session. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track AB 12?
Track AB 12 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on AB 12

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of AB 12

Last checked for changes 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →